Identification of the sites of 2-arachidonoylglycerol synthesis and action imply retrograde endocannabinoid signaling at both GABAergic and glutamatergic synapses in the ventral tegmental area

Neuropharmacology

Volumn 54, Issue 1, 2008, Pages 95-107

  Mátyás, Ferenc ^a   Urbán, Gabriella M ^a   Watanabe, Masahiko ^b   Mackie, Ken ^c   Zimmer, Andreas ^d   Freund, Tamás F ^a   Katona, István ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^b HOKKAIDO UNIVERSITY   (Japan)

^c INDIANA UNIVERSITY   (United States)

^d UNIVERSITY OF BONN   (Germany)

Author keywords

Addiction; Cannabinoid; CB1; DAGL; DGL ; Dopamine; Synaptic plasticity

Indexed keywords

2 ARACHIDONOYLGLYCEROL; 4 AMINOBUTYRIC ACID RECEPTOR; CANNABINOID 1 RECEPTOR; LIPOPROTEIN LIPASE; SN 1 DIACYLGLYCEROL LIPASE ALPHA; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING SITE; CELL MEMBRANE; CONTROLLED STUDY; DENDRITE; DOPAMINERGIC NERVE CELL; DRUG MECHANISM; ELECTRON MICROSCOPY; ENZYME LOCALIZATION; GABAERGIC TRANSMISSION; IN SITU HYBRIDIZATION; LIPOGENESIS; MALE; MOUSE; NERVE CELL; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION; VENTRAL TEGMENTUM;

ANIMALS; ARACHIDONIC ACIDS; ENDOCANNABINOIDS; GALACTOLIPIDS; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; GLYCERIDES; MALE; MICE; MICE, INBRED C57BL; RECEPTOR, CANNABINOID, CB1; SIGNAL TRANSDUCTION; SYNAPSES; TYROSINE 3-MONOOXYGENASE; VENTRAL TEGMENTAL AREA;

EID: 37349043211     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2007.05.028     Document Type: Article

References (55)

1. Anthony J.C., Warner L.A., and Kessler R.C. Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: basic findings from the National Comorbidity Survey. Exp. Clin. Psychopharmacol. 2 (1994) 244-268
2. Baude A., Nusser Z., Roberts J.D., Mulvihill E., McIlhinney R.A., and Somogyi P. The metabotropic glutamate receptor (mGluR1 alpha) is concentrated at perisynaptic membrane of neuronal subpopulations as detected by immunogold reaction. Neuron 11 (1993) 771-787
3. Bayer V.E., and Pickel V.M. GABA-labeled terminals form proportionally more synapses with dopaminergic neurons containing low densities of tyrosine hydroxylase-immunoreactivity in rat ventral tegmental area. Brain Res. 559 (1991) 44-55
4. Bisogno T., Berrendero F., Ambrosino G., Cebeira M., Ramos J.A., Fernandez-Ruiz J.J., and Di Marzo V. Brain regional distribution of endocannabinoids: implications for their biosynthesis and biological function. Biochem. Biophys. Res. Commun. 256 (1999) 377-380
5. Bisogno T., Howell F., Williams G., Minassi A., Cascio M.G., Ligresti A., Matias I., Schiano-Moriello A., Paul P., Williams E.J., Gangadharan U., Hobbs C., Di Marzo V., and Doherty P. Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain. J. Cell Biol. 163 (2003) 463-468
6. Carr D.B., and Sesack S.R. Projections from the rat prefrontal cortex to the ventral tegmental area: target specificity in the synaptic associations with mesoaccumbens and mesocortical neurons. J. Neurosci. 20 (2000) 3864-3873
7. Cheer J.F., Marsden C.A., Kendall D.A., and Mason R. Lack of response suppression follows repeated ventral tegmental cannabinoid administration: an in vitro electrophysiological study. Neuroscience 99 (2000) 661-667
8. Cheer J.F., Kendall D.A., Mason R., and Marsden C.A. Differential cannabinoid-induced electrophysiological effects in rat ventral tegmentum. Neuropharmacology 44 (2003) 633-641
9. Cheer J.F., Wassum K.M., Heien M.L., Phillips P.E., and Wightman R.M. Cannabinoids enhance subsecond dopamine release in the nucleus accumbens of awake rats. J. Neurosci. 24 (2004) 4393-4400
10. Cheer J.F., Wassum K.M., Sombers L.A., Heien M.L., Ariansen J.L., Aragona B.J., Phillips P.E., and Wightman R.M. Phasic dopamine release evoked by abused substances requires cannabinoid receptor activation. J. Neurosci. 27 (2007) 791-795
11. Chen J., Paredes W., Lowinson J.H., and Gardner E.L. Delta 9-tetrahydrocannabinol enhances presynaptic dopamine efflux in medial prefrontal cortex. Eur. J. Pharmacol. 190 (1990) 259-262
12. Egertová M., and Elphick M.R. Localisation of cannabinoid receptors in the rat brain using antibodies to the intracellular C-terminal tail of CB. J. Comp. Neurol. 422 (2000) 159-171
13. French E.D. delta9-Tetrahydrocannabinol excites rat VTA dopamine neurons through activation of cannabinoid CB1 but not opioid receptors. Neurosci. Lett. 226 (1997) 159-162
14. French E.D., Dillon K., and Wu X. Cannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigra. Neuroreport 8 (1997) 649-652
15. Freund T.F., Katona I., and Piomelli D. Role of endogenous cannabinoids in synaptic signaling. Physiol. Rev. 83 (2003) 1017-1066
16. Fukudome Y., Ohno-Shosaku T., Matsui M., Omori Y., Fukaya M., Tsubokawa H., Taketo M.M., Watanabe M., Manabe T., and Kano M. Two distinct classes of muscarinic action on hippocampal inhibitory synapses: M2-mediated direct suppression and M1/M3-mediated indirect suppression through endocannabinoid signalling. Eur J. Neurosci. 19 (2004) 2682-2692
17. Gardner E.L. Endocannabinoid signaling system and brain reward: emphasis on dopamine. Pharmacol. Biochem. Behav. 81 (2005) 263-284
18. Gessa G.L., Melis M., Muntoni A.L., and Diana M. Cannabinoids activate mesolimbic dopamine neurons by an action on cannabinoid CB1 receptors. Eur. J. Pharmacol. 341 (1998) 39-44
19. Grace A.A., and Onn S.P. Morphology and electrophysiological properties of immunocytochemically identified rat dopamine neurons recorded in vitro. J. Neurosci. 9 (1989) 3463-3481
20. Herkenham M., Lynn A.B., de Costa B.R., and Richfield E.K. Neuronal localization of cannabinoid receptors in the basal ganglia of the rat. Brain Res. 547 (1991) 267-274
21. Herkenham M., Lynn A.B., Johnson M.R., Melvin L.S., de Costa B.R., and Rice K.C. Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J. Neurosci. 11 (1991) 563-583
22. Julian M.D., Martin A.B., Cuellar B., Rodriguez De Fonseca F., Navarro M., Moratalla R., and Garcia-Segura L.M. Neuroanatomical relationship between type 1 cannabinoid receptors and dopaminergic systems in the rat basal ganglia. Neuroscience 119 (2003) 309-318
23. Katona I., Urbán G.M., Wallace M., Ledent C., Jung K.M., Piomelli D., Mackie K., and Freund T.F. Molecular composition of the endocannabinoid system at glutamatergic synapses. J. Neurosci. 26 (2006) 5628-5637
24. Kawamura Y., Fukaya M., Maejima T., Yoshida T., Miura E., Watanabe M., Ohno-Shosaku T., and Kano M. The CB1 cannabinoid receptor is the major cannabinoid receptor at excitatory presynaptic sites in the hippocampus and cerebellum. J. Neurosci. 26 (2006) 2991-3001
25. Klausberger T., Marton L.F., O'Neill J., Huck J.H., Dalezios Y., Fuentealba P., Suen W.Y., Papp E., Kaneko T., Watanabe M., Csicsvari J., and Somogyi P. Complementary roles of cholecystokinin- and parvalbumin-expressing GABAergic neurons in hippocampal network oscillations. J. Neurosci. 25 (2005) 9782-9793
26. Kofalvi A., Rodrigues R.J., Ledent C., Mackie K., Vizi E.S., Cunha R.A., and Sperlagh B. Involvement of cannabinoid receptors in the regulation of neurotransmitter release in the rodent striatum: a combined immunochemical and pharmacological analysis. J. Neurosci. 25 (2005) 2874-2884
27. Lupica C.R., and Riegel A.C. Endocannabinoid release from midbrain dopamine neurons: a potential substrate for cannabinoid receptor antagonist treatment of addiction. Neuropharmacology 48 (2005) 1105-1116
28. Lupica C.R., Riegel A.C., and Hoffman A.F. Marijuana and cannabinoid regulation of brain reward circuits. Br. J. Pharmacol. 143 (2004) 227-234
29. Mailleux P., and Vanderhaeghen J.J. Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistry. Neuroscience 48 (1992) 655-668
30. Maldonado R., Valverde O., and Berrendero F. Involvement of the endocannabinoid system in drug addiction. Trends Neurosci. 29 (2006) 225-232
31. Margolis E.B., Lock H., Hjelmstad G.O., and Fields H.L. The ventral tegmental area revisited: is there an electrophysiological marker for dopaminergic neurons?. J. Physiol. 577 (2006) 907-924
32. Melis M., Perra S., Muntoni A.L., Pillolla G., Lutz B., Marsicano G., Di Marzo V., Gessa G.L., and Pistis M. Prefrontal cortex stimulation induces 2-arachidonoyl-glycerol-mediated suppression of excitation in dopamine neurons. J. Neurosci. 24 (2004) 10707-10715
33. Melis M., Pistis M., Perra S., Muntoni A.L., Pillolla G., and Gessa G.L. Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors. J. Neurosci. 24 (2004) 53-62
34. Melis M., Pillolla G., Bisogno T., Minassi A., Petrosino S., Perra S., Muntoni A.L., Lutz B., Gessa G.L., Marsicano G., Di Marzo V., and Pistis M. Protective activation of the endocannabinoid system during ischemia in dopamine neurons. Neurobiol. Dis. 24 (2006) 15-27
35. Omelchenko N., and Sesack S.R. Glutamate synaptic inputs to ventral tegmental area neurons in the rat derive primarily from subcortical sources. Neuroscience 146 (2007) 1259-1274
36. Pickel V.M., Chan J., and Sesack S.R. Cellular substrates for interactions between dynorphin terminals and dopamine dendrites in rat ventral tegmental area and substantia nigra. Brain Res. 602 (1993) 275-289
37. Riegel A.C., and Lupica C.R. Independent presynaptic and postsynaptic mechanisms regulate endocannabinoid signaling at multiple synapses in the ventral tegmental area. J. Neurosci. 24 (2004) 11070-11078
38. Schultz W. Predictive reward signal of dopamine neurons. J. Neurophysiol. 80 (1998) 1-27
39. Sesack S.R., and Pickel V.M. Prefrontal cortical efferents in the rat synapse on unlabeled neuronal targets of catecholamine terminals in the nucleus accumbens septi and on dopamine neurons in the ventral tegmental area. J. Comp. Neurol. 320 (1992) 145-160
40. Sesack S.R., and Pickel V.M. Ultrastructural relationships between terminals immunoreactive for enkephalin, GABA, or both transmitters in the rat ventral tegmental area. Brain Res. 672 (1995) 261-275
41. Soler-Llavina G.J., and Sabatini B.L. Synapse-specific plasticity and compartmentalized signaling in cerebellar stellate cells. Nat. Neurosci. 9 (2006) 798-806
42. Steffensen S.C., Svingos A.L., Pickel V.M., and Henriksen S.J. Electrophysiological characterization of GABAergic neurons in the ventral tegmental area. J. Neurosci. 18 (1998) 8003-8015
43. Substance Abuse and Mental Health Services Administration, 2003. Results from the 2002 National Survey on Drug Use and Health: National Findings. Office of Applied Studies, NHSDA Series H-22, DHHS Publication No. SMA 03-3836, Rockville, MD.
44. Sugiura T., Kishimoto S., Oka S., and Gokoh M. Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand. Prog. Lipid Res. 45 (2006) 405-446
45. Swanson L.W. The projections of the ventral tegmental area and adjacent regions: a combined fluorescent retrograde tracer and immunofluorescence study in the rat. Brain Res. Bull. 9 (1982) 321-353
46. Szabó B., Muller T., and Koch H. Effects of cannabinoids on dopamine release in the corpus striatum and the nucleus accumbens in vitro. J. Neurochem. 73 (1999) 1084-1089
47. Szabó B., Siemes S., and Wallmichrath I. Inhibition of GABAergic neurotransmission in the ventral tegmental area by cannabinoids. Eur. J. Neurosci. 15 (2002) 2057-2061
48. Tanda G., Pontieri F.E., and Di Chiara G. Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism. Science 276 (1997) 2048-2050
49. Tsou K., Brown S., Sanudo-Pena M.C., Mackie K., and Walker J.M. Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 83 (1998) 393-411
50. Uchigashima M., Narushima M., Fukaya M., Katona I., Kano M., and Watanabe M. Subcellular arrangement of molecules for 2-arachidonoyl-glycerol-mediated retrograde signaling and its physiological contribution to synaptic modulation in the striatum. J. Neurosci. 27 (2007) 3663-3676
51. Wenger T., Moldrich G., and Furst S. Neuromorphological background of cannabis addiction. Brain Res. Bull. 61 (2003) 125-128
52. Wu X., and French E.D. Effects of chronic delta9-tetrahydrocannabinol on rat midbrain dopamine neurons: an electrophysiological assessment. Neuropharmacology 39 (2000) 391-398
53. Yoshida T., Fukaya M., Uchigashima M., Miura E., Kamiya H., Kano M., and Watanabe M. Localization of diacylglycerol lipase-alpha around postsynaptic spine suggests close proximity between production site of an endocannabinoid, 2-arachidonoyl-glycerol, and presynaptic cannabinoid CB1 receptor. J. Neurosci. 26 (2006) 4740-4751
54. Zangen A., Solinas M., Ikemoto S., Goldberg S.R., and Wise R.A. Two brain sites for cannabinoid reward. J. Neurosci. 26 (2006) 4901-4907
55. Zimmer A., Zimmer A.M., Hohmann A.G., Herkenham M., and Bonner T.I. Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 5780-5785